Gts Securities »

Marinus Pharmaceuticals shares owned by Gts Securities

Quarter-by-quarter ownership of Marinus Pharmaceuticals (MRNS) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Marinus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Marinus Pharmaceuticals held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marinus Pharmaceuticals by Gts Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $154k 17k 9.04

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Broadcom Put Option (AVGO)
Advanced Micro Devices Put Option (AMD)
Microstrategy Cl A New Put Option (MSTR)

View all positions for Gts Securities

Top funds holding Marinus Pharmaceuticals

Suvretta Capital Management
BlackRock
venBio Select Advisor
Franklin Resources
Sofinnova Ventures
Cormorant Asset Management
Jennison Associates
Vanguard Group
Eventide Asset Management
Adage Capital Partners GP
Lion Point Capital
Bleichroeder
GMT Capital Corp
Citadel Advisors
Bain Capital Life Sciences Investors

View all funds holding Marinus Pharmaceuticals